Selected research
Market Structure
Global AI-based Diabetic Eye Disease Screening System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI-based Diabetic Eye Disease Screening System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI-based Diabetic Eye Disease Screening System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI-based Diabetic Eye Disease Screening System include Remidio, Retmarker, VoxelCloud, Airdoc, Zhiyuan Huitu, IDx, LLC, Zhenhealth, Eyenuk and AEYE Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI-based Diabetic Eye Disease Screening System market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI-based Diabetic Eye Disease Screening System and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI-based Diabetic Eye Disease Screening System revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI-based Diabetic Eye Disease Screening System market size, projected growth trends, production technologies, key applications, and end-use industries.
AI-based Diabetic Eye Disease Screening System Segment by Company
Remidio
Retmarker
VoxelCloud
Airdoc
Zhiyuan Huitu
IDx, LLC
Zhenhealth
Eyenuk
AEYE Health
Optomed
AI-based Diabetic Eye Disease Screening System Segment by Type
On-premise
Cloud-based
Hybrid Mode
AI-based Diabetic Eye Disease Screening System Segment by Application
General Hospitals
Ophthalmology Hospitals
Diabetes Specialty Hospitals
AI-based Diabetic Eye Disease Screening System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Diabetic Eye Disease Screening System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-based Diabetic Eye Disease Screening System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Diabetic Eye Disease Screening System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI-based Diabetic Eye Disease Screening System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-based Diabetic Eye Disease Screening System industry.
Chapter 3: Detailed analysis of AI-based Diabetic Eye Disease Screening System companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-based Diabetic Eye Disease Screening Systemrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-premise
- Cloud-based
- Hybrid Mode
Applications
- General Hospitals
- Ophthalmology Hospitals
- Diabetes Specialty Hospitals
Companies covered
- Remidio
- Retmarker
- VoxelCloud
- Airdoc
- Zhiyuan Huitu
- IDx, LLC
- Zhenhealth
- Eyenuk
- AEYE Health
- Optomed
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 On-premise
- 1.2.3 Cloud-based
- 1.2.4 Hybrid Mode
- 1.3 Market Analysis by Application
- 1.3.1 Global AI-based Diabetic Eye Disease Screening System Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 General Hospitals
- 1.3.3 Ophthalmology Hospitals
- 1.3.4 Diabetes Specialty Hospitals
- 1.4 Global Market Growth Prospects
- 1.5 Global AI-based Diabetic Eye Disease Screening System Growth Trends by Region
- 1.5.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI-based Diabetic Eye Disease Screening System Market Size by Region (2021-2026)
- 1.5.3 AI-based Diabetic Eye Disease Screening System Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI-based Diabetic Eye Disease Screening System Market Dynamics
- 2.1 AI-based Diabetic Eye Disease Screening System Industry Trends
- 2.2 AI-based Diabetic Eye Disease Screening System Industry Drivers
- 2.3 AI-based Diabetic Eye Disease Screening System Industry Opportunities and Challenges
- 2.4 AI-based Diabetic Eye Disease Screening System Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI-based Diabetic Eye Disease Screening System Revenue by Company (2021-2026)
- 3.2 Global AI-based Diabetic Eye Disease Screening System Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI-based Diabetic Eye Disease Screening System Key Company Head office and Area Served
- 3.4 Global AI-based Diabetic Eye Disease Screening System Company, Product Type & Application
- 3.5 Global AI-based Diabetic Eye Disease Screening System Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI-based Diabetic Eye Disease Screening System Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI-based Diabetic Eye Disease Screening System Players Market Share by Revenue in 2025
- 3.6.3 2025 AI-based Diabetic Eye Disease Screening System Tier 1, Tier 2, and Tier 3
4 AI-based Diabetic Eye Disease Screening System Market by Type
- 4.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2032)
- 4.3 Global AI-based Diabetic Eye Disease Screening System Market Size Share by Type (2021-2032)
5 AI-based Diabetic Eye Disease Screening System Market by Application
- 5.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2032)
- 5.3 Global AI-based Diabetic Eye Disease Screening System Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Remidio
- 6.1.1 Remidio Company Information
- 6.1.2 Remidio Business Overview
- 6.1.3 Remidio AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Remidio AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.1.5 Remidio Recent Developments
- 6.2 Retmarker
- 6.2.1 Retmarker Company Information
- 6.2.2 Retmarker Business Overview
- 6.2.3 Retmarker AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Retmarker AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.2.5 Retmarker Recent Developments
- 6.3 VoxelCloud
- 6.3.1 VoxelCloud Company Information
- 6.3.2 VoxelCloud Business Overview
- 6.3.3 VoxelCloud AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 VoxelCloud AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.3.5 VoxelCloud Recent Developments
- 6.4 Airdoc
- 6.4.1 Airdoc Company Information
- 6.4.2 Airdoc Business Overview
- 6.4.3 Airdoc AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Airdoc AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.4.5 Airdoc Recent Developments
- 6.5 Zhiyuan Huitu
- 6.5.1 Zhiyuan Huitu Company Information
- 6.5.2 Zhiyuan Huitu Business Overview
- 6.5.3 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.5.5 Zhiyuan Huitu Recent Developments
- 6.6 IDx, LLC
- 6.6.1 IDx, LLC Company Information
- 6.6.2 IDx, LLC Business Overview
- 6.6.3 IDx, LLC AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 IDx, LLC AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.6.5 IDx, LLC Recent Developments
- 6.7 Zhenhealth
- 6.7.1 Zhenhealth Company Information
- 6.7.2 Zhenhealth Business Overview
- 6.7.3 Zhenhealth AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Zhenhealth AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.7.5 Zhenhealth Recent Developments
- 6.8 Eyenuk
- 6.8.1 Eyenuk Company Information
- 6.8.2 Eyenuk Business Overview
- 6.8.3 Eyenuk AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Eyenuk AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.8.5 Eyenuk Recent Developments
- 6.9 AEYE Health
- 6.9.1 AEYE Health Company Information
- 6.9.2 AEYE Health Business Overview
- 6.9.3 AEYE Health AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 AEYE Health AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.9.5 AEYE Health Recent Developments
- 6.10 Optomed
- 6.10.1 Optomed Company Information
- 6.10.2 Optomed Business Overview
- 6.10.3 Optomed AI-based Diabetic Eye Disease Screening System Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Optomed AI-based Diabetic Eye Disease Screening System Product Portfolio
- 6.10.5 Optomed Recent Developments
7 North America
- 7.1 North America AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 7.2 North America AI-based Diabetic Eye Disease Screening System Market Size by Type
- 7.2.1 North America AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
- 7.2.2 North America AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
- 7.2.3 North America AI-based Diabetic Eye Disease Screening System Market Share by Type (2021-2032)
- 7.3 North America AI-based Diabetic Eye Disease Screening System Market Size by Application
- 7.3.1 North America AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
- 7.3.2 North America AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
- 7.3.3 North America AI-based Diabetic Eye Disease Screening System Market Share by Application (2021-2032)
- 7.4 North America AI-based Diabetic Eye Disease Screening System Market Size by Country
- 7.4.1 North America AI-based Diabetic Eye Disease Screening System Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 7.4.3 North America AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 7.4.4 North America AI-based Diabetic Eye Disease Screening System Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 8.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Type
- 8.2.1 Europe AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
- 8.2.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
- 8.2.3 Europe AI-based Diabetic Eye Disease Screening System Market Share by Type (2021-2032)
- 8.3 Europe AI-based Diabetic Eye Disease Screening System Market Size by Application
- 8.3.1 Europe AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
- 8.3.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
- 8.3.3 Europe AI-based Diabetic Eye Disease Screening System Market Share by Application (2021-2032)
- 8.4 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country
- 8.4.1 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 8.4.3 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 8.4.4 Europe AI-based Diabetic Eye Disease Screening System Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 9.2 China AI-based Diabetic Eye Disease Screening System Market Size by Type
- 9.2.1 China AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
- 9.2.2 China AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
- 9.2.3 China AI-based Diabetic Eye Disease Screening System Market Share by Type (2021-2032)
- 9.3 China AI-based Diabetic Eye Disease Screening System Market Size by Application
- 9.3.1 China AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
- 9.3.2 China AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
- 9.3.3 China AI-based Diabetic Eye Disease Screening System Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 10.2 Asia AI-based Diabetic Eye Disease Screening System Market Size by Type
- 10.2.1 Asia AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
- 10.2.2 Asia AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
- 10.2.3 Asia AI-based Diabetic Eye Disease Screening System Market Share by Type (2021-2032)
- 10.3 Asia AI-based Diabetic Eye Disease Screening System Market Size by Application
- 10.3.1 Asia AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
- 10.3.2 Asia AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
- 10.3.3 Asia AI-based Diabetic Eye Disease Screening System Market Share by Application (2021-2032)
- 10.4 Asia AI-based Diabetic Eye Disease Screening System Market Size by Country
- 10.4.1 Asia AI-based Diabetic Eye Disease Screening System Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 10.4.3 Asia AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 10.4.4 Asia AI-based Diabetic Eye Disease Screening System Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type
- 11.2.1 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application
- 11.3.1 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country
- 11.4.1 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst